Panel finds in utero gene therapy proposal is premature.

Open Access

3 March 1999

journal article
research article
Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute

Vol. 91 (5) , 407-408
https://doi.org/10.1093/jnci/91.5.407

Abstract

How can consent be informed when the “patient” is a fetus? Is it appropriate to begin clinical trials involving prenatal gene therapy when the potential risks to the mother, the fetus, and the child's possible offspring are not fully understood? And how would such trials be designed?

Keywords

IN UTERO